One picture to understand Boji Pharmaceutical (02659) 2025 annual performance
Understanding Boji Pharmaceuticals (02659) 2025 Annual Performance in One Chart
Une chance sur un million
Related Articles
WISE ALLY INTL (09918) announced its performance for the year 2025, with a net loss attributable to equity holders of the Company amounting to HK$31.181 million, a turnaround from profit to loss compared to the previous year.
PICC GROUP (01339) Announces Annual Performance: Net Profit Attributable to Shareholders Increases by 9.62% to 46.207 billion yuan.
COMBA(02342) spent HK$0.8988 million on March 26 to buy back 562,000 shares.
WISE ALLY INTL (09918) announced its performance for the year 2025, with a net loss attributable to equity holders of the Company amounting to HK$31.181 million, a turnaround from profit to loss compared to the previous year.
PICC GROUP (01339) Announces Annual Performance: Net Profit Attributable to Shareholders Increases by 9.62% to 46.207 billion yuan.
COMBA(02342) spent HK$0.8988 million on March 26 to buy back 562,000 shares.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
